Skip to content

AtriCure ATRC Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Artivion logo
ArtivionAORT
ITG
Integer HoldingsITGR
Avanos Medical logo
Avanos MedicalAVNS
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's common stock, par value (in dollars per share)?
AtriCure (ATRC) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
How has AtriCure's common stock, par value (in dollars per share) changed year-over-year?
AtriCure's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for AtriCure's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), AtriCure's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.